| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Resistant Epilepsy | 15 | 2026 | 267 | 3.920 |
Why?
|
| Laser Therapy | 11 | 2025 | 239 | 3.640 |
Why?
|
| Epilepsy | 22 | 2026 | 886 | 2.800 |
Why?
|
| Hypothalamic Diseases | 7 | 2026 | 40 | 2.680 |
Why?
|
| Hamartoma | 7 | 2026 | 52 | 2.670 |
Why?
|
| Rhizotomy | 3 | 2024 | 17 | 2.140 |
Why?
|
| Magnetic Resonance Imaging | 28 | 2026 | 3909 | 2.040 |
Why?
|
| Cerebral Palsy | 3 | 2024 | 86 | 1.960 |
Why?
|
| Seizures | 10 | 2026 | 887 | 1.830 |
Why?
|
| Muscle Spasticity | 3 | 2024 | 56 | 1.600 |
Why?
|
| Stereotaxic Techniques | 8 | 2026 | 97 | 1.590 |
Why?
|
| Electroencephalography | 12 | 2026 | 865 | 1.560 |
Why?
|
| Hemispherectomy | 4 | 2024 | 26 | 1.470 |
Why?
|
| Electrocorticography | 4 | 2024 | 63 | 1.060 |
Why?
|
| Neurosurgical Procedures | 9 | 2024 | 313 | 1.030 |
Why?
|
| Neural Pathways | 2 | 2019 | 284 | 1.000 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2026 | 21 | 0.960 |
Why?
|
| Dystonia | 2 | 2019 | 174 | 0.910 |
Why?
|
| Epilepsies, Partial | 5 | 2020 | 85 | 0.900 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2026 | 113 | 0.880 |
Why?
|
| Child, Preschool | 38 | 2026 | 15037 | 0.850 |
Why?
|
| Child | 57 | 2026 | 26224 | 0.850 |
Why?
|
| Tuberous Sclerosis | 5 | 2025 | 146 | 0.740 |
Why?
|
| Treatment Outcome | 32 | 2026 | 12923 | 0.730 |
Why?
|
| Adolescent | 40 | 2026 | 20902 | 0.710 |
Why?
|
| Rest | 2 | 2019 | 63 | 0.680 |
Why?
|
| Deep Brain Stimulation | 5 | 2026 | 453 | 0.670 |
Why?
|
| Genetic Therapy | 1 | 2026 | 726 | 0.670 |
Why?
|
| Spinal Fusion | 10 | 2012 | 118 | 0.620 |
Why?
|
| Brain | 9 | 2024 | 3234 | 0.620 |
Why?
|
| Electrodes, Implanted | 5 | 2025 | 174 | 0.610 |
Why?
|
| Tumor Burden | 1 | 2020 | 238 | 0.610 |
Why?
|
| Hypothalamic Neoplasms | 1 | 2018 | 2 | 0.590 |
Why?
|
| Infant | 28 | 2026 | 13292 | 0.570 |
Why?
|
| Brain Mapping | 4 | 2024 | 385 | 0.560 |
Why?
|
| Male | 59 | 2026 | 65108 | 0.560 |
Why?
|
| Humans | 94 | 2026 | 131410 | 0.560 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2017 | 8 | 0.540 |
Why?
|
| Hyperthermia, Induced | 1 | 2017 | 56 | 0.520 |
Why?
|
| Poloxamer | 3 | 2007 | 14 | 0.500 |
Why?
|
| Female | 58 | 2026 | 71030 | 0.500 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2019 | 199 | 0.490 |
Why?
|
| Neurosurgery | 3 | 2026 | 73 | 0.490 |
Why?
|
| Retrospective Studies | 29 | 2026 | 17628 | 0.480 |
Why?
|
| Bone Screws | 6 | 2011 | 52 | 0.460 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 1 | 2014 | 14 | 0.440 |
Why?
|
| Anesthetics, Combined | 1 | 2014 | 7 | 0.440 |
Why?
|
| Microelectrodes | 1 | 2014 | 37 | 0.430 |
Why?
|
| Neurophysiological Monitoring | 1 | 2014 | 37 | 0.420 |
Why?
|
| Vagus Nerve Stimulation | 3 | 2022 | 62 | 0.410 |
Why?
|
| Follow-Up Studies | 9 | 2026 | 5267 | 0.410 |
Why?
|
| Young Adult | 16 | 2026 | 10081 | 0.410 |
Why?
|
| Hydrocephalus | 4 | 2011 | 292 | 0.390 |
Why?
|
| Neuroendoscopy | 4 | 2011 | 32 | 0.390 |
Why?
|
| Dystonic Disorders | 1 | 2014 | 98 | 0.390 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2012 | 98 | 0.390 |
Why?
|
| Neural Tube Defects | 3 | 2019 | 380 | 0.380 |
Why?
|
| Radiosurgery | 1 | 2013 | 129 | 0.370 |
Why?
|
| Hippocampus | 4 | 2024 | 804 | 0.370 |
Why?
|
| Anesthesia | 1 | 2014 | 210 | 0.350 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2020 | 613 | 0.350 |
Why?
|
| Kyphosis | 5 | 2012 | 21 | 0.350 |
Why?
|
| Predictive Value of Tests | 3 | 2025 | 2297 | 0.340 |
Why?
|
| Surface-Active Agents | 3 | 2007 | 30 | 0.340 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2023 | 283 | 0.340 |
Why?
|
| Cervical Vertebrae | 5 | 2012 | 113 | 0.310 |
Why?
|
| Postoperative Complications | 11 | 2019 | 3113 | 0.290 |
Why?
|
| Spine | 5 | 2012 | 147 | 0.280 |
Why?
|
| Quinolinic Acid | 2 | 2004 | 10 | 0.280 |
Why?
|
| Electric Stimulation Therapy | 2 | 2026 | 85 | 0.280 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2026 | 84 | 0.270 |
Why?
|
| Workload | 2 | 2026 | 153 | 0.270 |
Why?
|
| Cohort Studies | 6 | 2025 | 5119 | 0.260 |
Why?
|
| Lumbar Vertebrae | 3 | 2011 | 109 | 0.250 |
Why?
|
| Homovanillic Acid | 1 | 2026 | 30 | 0.240 |
Why?
|
| Neuroprotective Agents | 3 | 2019 | 161 | 0.240 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2005 | 13 | 0.230 |
Why?
|
| Magnetoencephalography | 1 | 2025 | 41 | 0.230 |
Why?
|
| Spinal Neoplasms | 3 | 2011 | 70 | 0.230 |
Why?
|
| Surgical Wound Infection | 2 | 2018 | 270 | 0.220 |
Why?
|
| Thoracic Vertebrae | 5 | 2012 | 67 | 0.220 |
Why?
|
| Sensitivity and Specificity | 3 | 2019 | 2142 | 0.210 |
Why?
|
| Necrosis | 1 | 2004 | 194 | 0.210 |
Why?
|
| Internship and Residency | 2 | 2026 | 1213 | 0.210 |
Why?
|
| Catheterization | 1 | 2005 | 233 | 0.210 |
Why?
|
| Injections, Spinal | 2 | 2019 | 132 | 0.210 |
Why?
|
| Education, Medical, Graduate | 2 | 2026 | 545 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 68 | 0.190 |
Why?
|
| Tomography, X-Ray Computed | 10 | 2012 | 2114 | 0.190 |
Why?
|
| Baclofen | 2 | 2019 | 43 | 0.190 |
Why?
|
| Muscle Relaxants, Central | 2 | 2019 | 38 | 0.190 |
Why?
|
| Terminology as Topic | 1 | 2024 | 227 | 0.190 |
Why?
|
| Genetic Vectors | 1 | 2026 | 901 | 0.190 |
Why?
|
| Functional Laterality | 2 | 2020 | 183 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 260 | 0.180 |
Why?
|
| Quadriplegia | 1 | 2021 | 35 | 0.170 |
Why?
|
| Intracranial Aneurysm | 2 | 2012 | 82 | 0.160 |
Why?
|
| Reoperation | 4 | 2018 | 835 | 0.160 |
Why?
|
| Infratentorial Neoplasms | 2 | 2010 | 37 | 0.160 |
Why?
|
| Microsurgery | 2 | 2011 | 64 | 0.160 |
Why?
|
| Criminal Psychology | 1 | 1999 | 3 | 0.150 |
Why?
|
| Ependymoma | 1 | 2021 | 153 | 0.150 |
Why?
|
| Dengue Vaccines | 1 | 2019 | 15 | 0.150 |
Why?
|
| Day Care, Medical | 1 | 1999 | 11 | 0.150 |
Why?
|
| Residential Treatment | 1 | 1999 | 13 | 0.150 |
Why?
|
| Social Behavior Disorders | 1 | 1999 | 12 | 0.150 |
Why?
|
| Psychology, Adolescent | 1 | 1999 | 35 | 0.150 |
Why?
|
| Crime | 1 | 1999 | 26 | 0.150 |
Why?
|
| Skull Fractures | 1 | 1999 | 47 | 0.150 |
Why?
|
| Astrocytoma | 2 | 2010 | 102 | 0.150 |
Why?
|
| MPTP Poisoning | 1 | 2019 | 3 | 0.150 |
Why?
|
| Ventriculoperitoneal Shunt | 2 | 2010 | 63 | 0.150 |
Why?
|
| Juvenile Delinquency | 1 | 1999 | 25 | 0.150 |
Why?
|
| Substantia Nigra | 1 | 2019 | 35 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2004 | 711 | 0.150 |
Why?
|
| Hematoma | 1 | 1999 | 90 | 0.150 |
Why?
|
| Craniotomy | 2 | 2017 | 102 | 0.150 |
Why?
|
| Ghrelin | 1 | 2019 | 57 | 0.150 |
Why?
|
| Single-Blind Method | 1 | 2019 | 241 | 0.150 |
Why?
|
| Spasms, Infantile | 1 | 2020 | 165 | 0.150 |
Why?
|
| Dopaminergic Neurons | 1 | 2019 | 61 | 0.140 |
Why?
|
| Joint Instability | 2 | 2009 | 57 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2021 | 357 | 0.140 |
Why?
|
| Meningomyelocele | 2 | 2012 | 272 | 0.140 |
Why?
|
| Embolization, Therapeutic | 2 | 2012 | 223 | 0.140 |
Why?
|
| Cerebral Cortex | 3 | 2018 | 468 | 0.140 |
Why?
|
| Prospective Studies | 3 | 2019 | 6481 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2019 | 330 | 0.140 |
Why?
|
| Scoliosis | 4 | 2012 | 145 | 0.140 |
Why?
|
| Electrocoagulation | 1 | 2018 | 32 | 0.140 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2018 | 35 | 0.140 |
Why?
|
| Pyrimidines | 1 | 2021 | 443 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2018 | 397 | 0.130 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 1295 | 0.130 |
Why?
|
| Language | 1 | 2018 | 218 | 0.130 |
Why?
|
| Neurons | 3 | 2010 | 1990 | 0.130 |
Why?
|
| Inflammation | 1 | 2004 | 1488 | 0.130 |
Why?
|
| Tissue Banks | 1 | 2016 | 29 | 0.120 |
Why?
|
| Nervous System Diseases | 2 | 2012 | 402 | 0.120 |
Why?
|
| Radiography | 7 | 2012 | 760 | 0.120 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2017 | 121 | 0.120 |
Why?
|
| Ankyrins | 1 | 2016 | 96 | 0.120 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2015 | 3 | 0.120 |
Why?
|
| Fornix, Brain | 1 | 2015 | 23 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 2984 | 0.120 |
Why?
|
| Laminectomy | 2 | 2019 | 24 | 0.110 |
Why?
|
| Encephalitis | 1 | 2016 | 119 | 0.110 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 138 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2019 | 781 | 0.110 |
Why?
|
| Emergency Medical Services | 2 | 2010 | 421 | 0.110 |
Why?
|
| Perioperative Care | 1 | 2017 | 215 | 0.110 |
Why?
|
| Nicardipine | 1 | 2014 | 16 | 0.110 |
Why?
|
| Anesthetics, Dissociative | 1 | 2014 | 18 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2007 | 1148 | 0.110 |
Why?
|
| Costs and Cost Analysis | 1 | 2014 | 155 | 0.110 |
Why?
|
| Oxygen | 1 | 2017 | 552 | 0.100 |
Why?
|
| Dexmedetomidine | 1 | 2014 | 47 | 0.100 |
Why?
|
| Monitoring, Intraoperative | 2 | 2011 | 130 | 0.100 |
Why?
|
| Wakefulness | 1 | 2014 | 103 | 0.100 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2011 | 57 | 0.100 |
Why?
|
| Vasospasm, Intracranial | 2 | 2004 | 18 | 0.100 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 364 | 0.100 |
Why?
|
| Hypnotics and Sedatives | 1 | 2014 | 133 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 428 | 0.100 |
Why?
|
| Rett Syndrome | 1 | 2015 | 226 | 0.100 |
Why?
|
| Neuralgia | 1 | 2013 | 51 | 0.100 |
Why?
|
| Internal Fixators | 1 | 2012 | 12 | 0.100 |
Why?
|
| Arthrodesis | 1 | 2012 | 14 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2012 | 32 | 0.090 |
Why?
|
| Piperidines | 1 | 2014 | 232 | 0.090 |
Why?
|
| Memory | 1 | 2015 | 358 | 0.090 |
Why?
|
| Tuberculosis, Spinal | 1 | 2012 | 9 | 0.090 |
Why?
|
| Intracranial Hemorrhages | 1 | 2012 | 79 | 0.090 |
Why?
|
| Sympathectomy | 1 | 2011 | 8 | 0.090 |
Why?
|
| Cranial Sutures | 1 | 2012 | 36 | 0.090 |
Why?
|
| Osteoblastoma | 1 | 2011 | 3 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 235 | 0.090 |
Why?
|
| Amenorrhea | 1 | 2011 | 19 | 0.090 |
Why?
|
| Posters as Topic | 1 | 2011 | 7 | 0.090 |
Why?
|
| Corpus Callosum | 1 | 2012 | 106 | 0.090 |
Why?
|
| Cauda Equina | 1 | 2011 | 9 | 0.090 |
Why?
|
| Thoracoscopy | 1 | 2011 | 44 | 0.090 |
Why?
|
| Ventriculostomy | 1 | 2011 | 46 | 0.090 |
Why?
|
| Publications | 1 | 2011 | 36 | 0.090 |
Why?
|
| Intervertebral Disc Displacement | 1 | 2011 | 19 | 0.090 |
Why?
|
| Diskectomy | 1 | 2011 | 13 | 0.090 |
Why?
|
| Peer Review, Research | 1 | 2011 | 45 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 422 | 0.090 |
Why?
|
| Fracture Fixation | 1 | 2011 | 29 | 0.090 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 31 | 0.090 |
Why?
|
| Rats | 4 | 2007 | 3454 | 0.090 |
Why?
|
| Adult | 9 | 2026 | 31628 | 0.080 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2010 | 5 | 0.080 |
Why?
|
| Sleep | 1 | 2014 | 373 | 0.080 |
Why?
|
| Cisterna Magna | 3 | 2007 | 4 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2011 | 83 | 0.080 |
Why?
|
| Ketamine | 1 | 2014 | 226 | 0.080 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2010 | 21 | 0.080 |
Why?
|
| Vein of Galen Malformations | 1 | 2010 | 15 | 0.080 |
Why?
|
| Subarachnoid Space | 1 | 2010 | 24 | 0.080 |
Why?
|
| Malformations of Cortical Development | 1 | 2010 | 61 | 0.080 |
Why?
|
| Respiratory Tract Fistula | 1 | 2010 | 17 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2011 | 185 | 0.080 |
Why?
|
| Polyesters | 1 | 2010 | 36 | 0.080 |
Why?
|
| Pleural Diseases | 1 | 2010 | 33 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2011 | 137 | 0.080 |
Why?
|
| Critical Pathways | 1 | 2010 | 74 | 0.080 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2010 | 126 | 0.080 |
Why?
|
| Spinal Cord | 3 | 2023 | 266 | 0.080 |
Why?
|
| Prosthesis Failure | 1 | 2010 | 148 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2012 | 156 | 0.080 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2009 | 7 | 0.080 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 155 | 0.080 |
Why?
|
| Thoracotomy | 1 | 2010 | 107 | 0.080 |
Why?
|
| Neuroendoscopes | 1 | 2009 | 2 | 0.080 |
Why?
|
| Chondroma | 1 | 2009 | 5 | 0.080 |
Why?
|
| Atlanto-Axial Joint | 1 | 2009 | 21 | 0.070 |
Why?
|
| Cervical Atlas | 1 | 2009 | 8 | 0.070 |
Why?
|
| Choroid Plexus | 1 | 2009 | 27 | 0.070 |
Why?
|
| Rhabdoid Tumor | 1 | 2009 | 48 | 0.070 |
Why?
|
| Hydrothorax | 1 | 2008 | 11 | 0.070 |
Why?
|
| Ophthalmoplegia | 1 | 2009 | 52 | 0.070 |
Why?
|
| Arteriovenous Malformations | 1 | 2009 | 47 | 0.070 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2009 | 33 | 0.070 |
Why?
|
| Subarachnoid Hemorrhage | 2 | 2012 | 64 | 0.070 |
Why?
|
| Periosteum | 1 | 2009 | 32 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2018 | 2566 | 0.070 |
Why?
|
| Corpus Striatum | 2 | 2007 | 97 | 0.070 |
Why?
|
| Geography | 1 | 2008 | 119 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2008 | 81 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 463 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2019 | 1223 | 0.070 |
Why?
|
| Cerebral Hemorrhage, Traumatic | 1 | 2007 | 3 | 0.070 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 1312 | 0.060 |
Why?
|
| Patient Transfer | 1 | 2008 | 110 | 0.060 |
Why?
|
| Animals | 10 | 2019 | 34321 | 0.060 |
Why?
|
| Cerebellar Neoplasms | 1 | 2010 | 320 | 0.060 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 322 | 0.060 |
Why?
|
| Medulloblastoma | 1 | 2010 | 384 | 0.060 |
Why?
|
| Recurrence | 2 | 2020 | 1476 | 0.060 |
Why?
|
| Hospitalization | 1 | 2014 | 1933 | 0.060 |
Why?
|
| Neuronavigation | 1 | 2005 | 10 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2026 | 262 | 0.050 |
Why?
|
| Thalamic Nuclei | 1 | 2024 | 18 | 0.050 |
Why?
|
| Length of Stay | 3 | 2019 | 1393 | 0.050 |
Why?
|
| Heart-Assist Devices | 1 | 2012 | 991 | 0.050 |
Why?
|
| Magnesium Sulfate | 1 | 2004 | 51 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2007 | 804 | 0.050 |
Why?
|
| Age Factors | 4 | 2011 | 2869 | 0.050 |
Why?
|
| Consensus | 1 | 2026 | 570 | 0.050 |
Why?
|
| Benchmarking | 1 | 2024 | 138 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2002 | 19 | 0.050 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2011 | 1170 | 0.050 |
Why?
|
| Nitroprusside | 1 | 2002 | 36 | 0.050 |
Why?
|
| Vagus Nerve | 1 | 2022 | 48 | 0.050 |
Why?
|
| Quality of Life | 2 | 2024 | 2105 | 0.050 |
Why?
|
| Disease Management | 1 | 2026 | 562 | 0.050 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2023 | 182 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2026 | 1513 | 0.040 |
Why?
|
| Receptor, trkB | 1 | 2021 | 23 | 0.040 |
Why?
|
| Artifacts | 1 | 2022 | 109 | 0.040 |
Why?
|
| Middle Aged | 5 | 2018 | 28807 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 4683 | 0.040 |
Why?
|
| Electrodes | 1 | 2020 | 81 | 0.040 |
Why?
|
| Macrophages | 1 | 2004 | 663 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 139 | 0.040 |
Why?
|
| Regional Medical Programs | 1 | 1999 | 18 | 0.040 |
Why?
|
| Utah | 1 | 1999 | 83 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 444 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 125 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 1999 | 203 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2021 | 421 | 0.040 |
Why?
|
| Family Therapy | 1 | 1999 | 34 | 0.040 |
Why?
|
| World Health Organization | 1 | 2019 | 115 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2019 | 174 | 0.040 |
Why?
|
| Receptors, Ghrelin | 1 | 2019 | 29 | 0.040 |
Why?
|
| Seroepidemiologic Studies | 1 | 2019 | 167 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 1999 | 58 | 0.040 |
Why?
|
| Immunization Programs | 1 | 2019 | 66 | 0.040 |
Why?
|
| Dengue Virus | 1 | 2019 | 134 | 0.030 |
Why?
|
| Dengue | 1 | 2019 | 123 | 0.030 |
Why?
|
| Operative Time | 1 | 2019 | 205 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 168 | 0.030 |
Why?
|
| Periodicity | 1 | 2018 | 49 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 101 | 0.030 |
Why?
|
| Apoptosis | 1 | 2004 | 1862 | 0.030 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 50 | 0.030 |
Why?
|
| Data Collection | 1 | 1999 | 371 | 0.030 |
Why?
|
| Equipment Failure | 1 | 2018 | 128 | 0.030 |
Why?
|
| Time Factors | 3 | 2010 | 6272 | 0.030 |
Why?
|
| Obesity | 1 | 2009 | 2378 | 0.030 |
Why?
|
| Checklist | 1 | 2018 | 100 | 0.030 |
Why?
|
| Public Health | 1 | 2019 | 276 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2018 | 228 | 0.030 |
Why?
|
| Parvalbumins | 1 | 2016 | 36 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 471 | 0.030 |
Why?
|
| Device Removal | 1 | 2018 | 222 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Spatial Learning | 1 | 2015 | 15 | 0.030 |
Why?
|
| Mice | 3 | 2019 | 18464 | 0.030 |
Why?
|
| Software | 1 | 2021 | 752 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2016 | 421 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2016 | 149 | 0.030 |
Why?
|
| Interneurons | 1 | 2016 | 146 | 0.030 |
Why?
|
| Long-Term Potentiation | 1 | 2015 | 105 | 0.030 |
Why?
|
| Islets of Langerhans | 1 | 1995 | 160 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 314 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 1272 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 588 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1831 | 0.030 |
Why?
|
| Fear | 1 | 2015 | 198 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 769 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2018 | 995 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2018 | 643 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 305 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2015 | 224 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 1167 | 0.030 |
Why?
|
| Macaca fascicularis | 2 | 2004 | 82 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 1169 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 489 | 0.020 |
Why?
|
| Spondylitis | 1 | 2012 | 8 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2005 | 8584 | 0.020 |
Why?
|
| Ischemia | 1 | 1995 | 352 | 0.020 |
Why?
|
| Head Protective Devices | 1 | 2012 | 24 | 0.020 |
Why?
|
| Patient Positioning | 1 | 2012 | 53 | 0.020 |
Why?
|
| Back Pain | 1 | 2012 | 30 | 0.020 |
Why?
|
| Ganglia, Sympathetic | 1 | 2011 | 8 | 0.020 |
Why?
|
| Stellate Ganglion | 1 | 2011 | 9 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1610 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 165 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2015 | 1569 | 0.020 |
Why?
|
| Atenolol | 1 | 2011 | 44 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 1624 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2018 | 706 | 0.020 |
Why?
|
| Third Ventricle | 1 | 2011 | 32 | 0.020 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2011 | 6 | 0.020 |
Why?
|
| Syncope | 1 | 2011 | 49 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2015 | 565 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 2363 | 0.020 |
Why?
|
| Pyramidal Tracts | 1 | 2011 | 37 | 0.020 |
Why?
|
| Gait | 1 | 2012 | 146 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1995 | 379 | 0.020 |
Why?
|
| Fentanyl | 1 | 2011 | 54 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 695 | 0.020 |
Why?
|
| ROC Curve | 1 | 2012 | 615 | 0.020 |
Why?
|
| Insulin | 1 | 1995 | 1145 | 0.020 |
Why?
|
| Organizational Policy | 1 | 2010 | 50 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2010 | 89 | 0.020 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2010 | 10 | 0.020 |
Why?
|
| Skull | 1 | 2012 | 153 | 0.020 |
Why?
|
| Ganglioneuroma | 1 | 2010 | 17 | 0.020 |
Why?
|
| Safety | 1 | 2011 | 215 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2011 | 249 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2011 | 215 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 2010 | 37 | 0.020 |
Why?
|
| Anesthesia, General | 1 | 2011 | 128 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2010 | 116 | 0.020 |
Why?
|
| Cognition | 1 | 2015 | 842 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2012 | 300 | 0.020 |
Why?
|
| Surgery, Plastic | 1 | 2012 | 114 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2017 | 3448 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 364 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 2010 | 106 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 1839 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2010 | 293 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2011 | 213 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 209 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2009 | 101 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2010 | 143 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 456 | 0.020 |
Why?
|
| Midwestern United States | 1 | 2008 | 16 | 0.020 |
Why?
|
| Anthropometry | 1 | 2009 | 190 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 147 | 0.020 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2010 | 200 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 827 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 1404 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2856 | 0.020 |
Why?
|
| Acute Disease | 1 | 2010 | 1152 | 0.020 |
Why?
|
| Injections, Intraventricular | 1 | 2007 | 53 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1343 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 1255 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2007 | 23 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2011 | 793 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 553 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2007 | 90 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1831 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3411 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2010 | 794 | 0.010 |
Why?
|
| Biopsy | 1 | 2009 | 1247 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2007 | 741 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 1522 | 0.010 |
Why?
|
| Risk Factors | 2 | 2010 | 10947 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 853 | 0.010 |
Why?
|
| Comorbidity | 1 | 2009 | 1589 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2009 | 1251 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 2146 | 0.010 |
Why?
|
| Algorithms | 1 | 2010 | 1683 | 0.010 |
Why?
|
| Injections | 1 | 2002 | 114 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2002 | 90 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 2002 | 106 | 0.010 |
Why?
|
| Cerebral Arteries | 1 | 2002 | 80 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 352 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2002 | 314 | 0.010 |
Why?
|
| Prognosis | 1 | 2010 | 4941 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 3691 | 0.010 |
Why?
|
| United States | 1 | 2014 | 11784 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 195 | 0.010 |
Why?
|
| Temperature | 1 | 1995 | 294 | 0.010 |
Why?
|
| Kinetics | 1 | 1995 | 1101 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1995 | 502 | 0.010 |
Why?
|